UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.08B |
| 2 |
UBS Group
UBS
|
+$643M |
| 3 |
Southwest Airlines
LUV
|
+$588M |
| 4 |
Medtronic
MDT
|
+$505M |
| 5 |
Workday
WDAY
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.51B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$976M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$803M |
| 5 |
Chevron
CVX
|
+$688M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.35% |
| 2 | Technology | 17.79% |
| 3 | Financials | 9.18% |
| 4 | Industrials | 6.66% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8601
Data I/O
DAIO
$31M
| $9.07K | ﹤0.01% |
+2,716
| New | +$8.79K |
2025 Q3
0 quarters
|
|
8602
Rockwell Medical
RMTI
$34.9M
| $9.06K | ﹤0.01% |
755
-417
| -36% | -$5.1K |
2014 Q4
43 quarters
|
|
|
PRPH
8603
DELISTED
ProPhase Labs
PRPH
| $9.04K | ﹤0.01% |
1,974
-3,793
| -66% | -$14.7K |
2024 Q3
4 quarters
|
|
8604
Garden Stage Ltd
GSIW
$13.9M
| $9.03K | ﹤0.01% |
301
+216
| +254% | +$18.5K |
2024 Q2
5 quarters
|
|
|
IMDX
8605
Insight Molecular Diagnostics
IMDX
$113M
| $9.01K | ﹤0.01% |
2,714
-12,651
| -82% | -$35.7K |
2018 Q4
27 quarters
|
|
8606
T Stamp
IDAI
$18.3M
| $9K | ﹤0.01% |
2,744
+2,686
| +4,631% | +$8.03K |
2025 Q1
2 quarters
|
|
8607
ProShares Short High Yield
SJB
$52.6M
| $8.96K | ﹤0.01% |
583
+568
| +3,787% | +$8.86K |
2022 Q3
12 quarters
|
|
8608
Touchstone Securitized Income ETF
TSEC
$168M
| $8.92K | ﹤0.01% |
340
+189
| +125% | +$4.96K |
2025 Q2
1 quarter
|
|
8609
PIMCO Ultra Short Government Active ETF
BILZ
$866M
| $8.9K | ﹤0.01% |
88
-6,417
| -99% | -$648K |
2024 Q2
5 quarters
|
|
|
PAII.U
8610
Pyrophyte Acquisition Corp II Units
PAII.U
| $8.89K | ﹤0.01% |
+878
| New | +$8.84K |
2025 Q3
0 quarters
|
|
8611
Matthews Emerging Markets Discovery Active ETF
MEMS
$21.2M
| $8.89K | ﹤0.01% |
332
-11
| -3% | -$292 |
2024 Q4
3 quarters
|
|
8612
Alpha Tau Medical Warrant
DRTSW
$94.8M
| $8.84K | ﹤0.01% |
25,620
-2,769
| -10% | -$786 |
2024 Q1
6 quarters
|
|
8613
TCW Transform Supply Chain ETF
SUPP
$12.1M
| $8.78K | ﹤0.01% |
124
-15
| -11% | -$1.04K |
2024 Q2
5 quarters
|
|
8614
Hartford Multifactor Small Cap ETF
ROSC
$50M
| $8.78K | ﹤0.01% |
+193
| New | +$8.48K |
2025 Q3
0 quarters
|
|
|
CEE
8615
Central and Eastern Europe Fund
CEE
$118M
| $8.77K | ﹤0.01% |
571
+356
| +166% | +$5.7K |
2014 Q4
43 quarters
|
|
8616
Innovator US Equity Buffer ETF August
BAUG
$272M
| $8.77K | ﹤0.01% |
179
-11,391
| -98% | -$542K |
2023 Q2
9 quarters
|
|
|
ALCYU
8617
DELISTED
Alchemy Investments Acquisition Corp 1 Units
ALCYU
| $8.77K | ﹤0.01% |
800
| – | – |
2025 Q1
2 quarters
|
|
8618
NewAmsterdam Pharma Warrant
NAMSW
| $8.76K | ﹤0.01% |
512
-481
| -48% | -$6.19K |
2024 Q4
3 quarters
|
|
8619
CALL
Avantor
AVTR
$10.4B
| $8.74K | ﹤0.01% |
700
| – | – |
2024 Q2
5 quarters
|
|
8620
Investcorp Credit Management BDC
ICMB
$11.4M
| $8.71K | ﹤0.01% |
+3,133
| New | +$8.87K |
2025 Q3
0 quarters
|
|
|
XCH
8621
XCHG Ltd
XCH
$12.7M
| $8.69K | ﹤0.01% |
337
+215
| +176% | +$5.48K |
2024 Q4
3 quarters
|
|
|
MRNO
8622
Murano Global Investments
MRNO
$24M
| $8.67K | ﹤0.01% |
3,368
-2,520
| -43% | -$15.6K |
2024 Q4
3 quarters
|
|
8623
US Treasury 3 Year Note ETF
UTRE
$10.6M
| $8.67K | ﹤0.01% |
174
| – | – |
2025 Q1
2 quarters
|
|
|
RDAC
8624
Rising Dragon Acquisition Corp
RDAC
$32.7M
| $8.67K | ﹤0.01% |
+832
| New | +$8.62K |
2025 Q3
0 quarters
|
|
8625
ProShares UltraShort Bitcoin ETF
SBIT
$128M
| $8.65K | ﹤0.01% |
298
| – | – |
2024 Q2
5 quarters
|
|
Similar funds
UBS Group's Q3 2025 Portfolio in Review
As of Q3 2025, UBS Group held 11,340 positions worth $638B, up 11% from $578B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group's Q3 2025 filing shows 1,171 new, 4,183 increased, 4,475 reduced and 1,086 closed positions. Its largest new stake was Paramount Skydance Corp: 13,287,677 shares worth $251M. The largest sale was NVIDIA, an estimated $1.51B.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q3 2025 buy was Paramount Skydance Corp: 13,287,677 shares worth $251M.
- UBS Group added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $1.08B increase.
- UBS Group's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $1.51B.
- UBS Group fully exited Hess in Q3 2025, selling an estimated $442M.
- UBS Group's ten largest holdings make up 16% of its $638B portfolio in Q3 2025.
- UBS Group opened 1,171 new positions and closed 1,086 in Q3 2025.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $638B.
Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.